Advertisement

Cost/benefit analysis of chlorhexidine-silver sulfadiazine-impregnated venous catheters for femoral access

      Highlights

      • CHSS-impregnated catheters for femoral venous access reduced the risk of CRBSI.
      • CHSS-impregnated catheters for femoral venous access saved costs.
      • CHSS-impregnated catheters were not associated with allergic reactions.
      Sixty-four patients with chlorhexidine-silver sulfadiazine-impregnated catheters had a lower rate of catheter-related bloodstream infection and lower central venous catheter-related costs per catheter day than 190 patients with a standard catheter.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Vincent J.L.
        • Bihari D.J.
        • Suter P.M.
        • Bruining H.A.
        • White J.
        • Nicolas-Chanoin M.H.
        • et al.
        The prevalence of nosocomial infection in Intensive Care Units in EuropeResults of the European Prevalence of Infection in Intensive Care (EPIC) Study.The EPIC International Advisory Committee.
        JAMA. 1995; 274: 639-644
        • Siempos I.I.
        • Kopterides P.
        • Tsangaris I.
        • Dimopoulou I.
        • Armaganidis A.E.
        Impact of catheter-related bloodstream infections on the mortality of critically ill patients: a meta-analysis.
        Crit Care Med. 2009; 37: 2283-2289
        • Lambert M.L.
        • Suetens C.
        • Savey A.
        • Palomar M.
        • Hiesmayr M.
        • Morales I.
        • et al.
        Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study.
        Lancet Infect Dis. 2011; 11: 30-38
        • Laupland K.B.
        • Lee H.
        • Gregson D.B.
        • Manns B.J.
        Cost of intensive care unit-acquired bloodstream infections.
        J Hosp Infect. 2006; 63: 124-132
        • Veenstra D.L.
        • Saint S.
        • Saha S.
        • Lumley T.
        • Sullivan S.D.
        Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis.
        JAMA. 1999; 281: 261-267
        • Hockenhull J.C.
        • Dwan K.
        • Boland A.
        • Smith G.
        • Bagust A.
        • Dündar Y.
        • et al.
        The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation.
        Health Technol Assess. 2008; 12: 1-154
        • Veenstra D.L.
        • Saint S.
        • Sullivan S.D.
        Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection.
        JAMA. 1999; 282: 554-560
        • Shorr A.F.
        • Humphreys C.W.
        • Helman D.L.
        New choices for central venous catheters: potential financial implications.
        Chest. 2003; 124: 275-284
        • Pittet D.
        • Tarara D.
        • Wenzel R.P.
        Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality.
        JAMA. 1994; 271: 1598-1601
        • Dimick J.B.
        • Pelz R.K.
        • Consunji R.
        • Swoboda S.M.
        • Hendrix C.W.
        • Lipsett P.A.
        Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit.
        Arch Surg. 2001; 136: 229-234
        • Maki D.G.
        • Weise C.E.
        • Sarafin H.W.
        A semiquantitative culture method for identifying intravenous catheter-related infection.
        N Engl J Med. 1977; 296: 1305-1309
        • Lorente L.
        • Lecuona M.
        • Jiménez A.
        • Santacreu R.
        • Raja L.
        • González O.
        • et al.
        Chlorhexidine-silver sulfadiazine-impregnated venous catheters save costs.
        Am J Infect Control. 2014; 42: 321-324
        • Lorente L.
        • Lecuona M.
        • Ramos M.J.
        • Jiménez A.
        • Mora M.L.
        • Sierra A.
        The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia.
        Clin Infect Dis. 2008; 47: 1171-1175
        • Lorente L.
        • Lecuona M.
        • Ramos M.J.
        • Jiménez A.
        • Mora M.L.
        • Sierra A.
        Lower assistance costs using rifampicin-miconazole-impregnated catheters than standard catheters.
        Am J Infect Control. 2011; 39: 895-897
        • Lorente L.
        • Lecuona M.
        • Ramos M.J.
        • Jiménez A.
        • Mora M.L.
        • Sierra A.
        Rifampicin-miconazole-impregnated catheters save cost in jugular venous sites with tracheostomy.
        Eur J Clin Microbiol Infect Dis. 2012; 31: 1833-1836
        • O’Grady N.P.
        • Alexander M.
        • Burns L.A.
        • Dellinger E.P.
        • Garland J.
        • Heard S.O.
        • et al.
        • Healthcare Infection Control Practices Advisory Committee (HICPAC)
        Guidelines for the prevention of intravascular catheter-related infections.
        Clin Infect Dis. 2011; 52: e162-e193
        • Lorente L.
        • Henry C.
        • Martín M.M.
        • Jiménez A.
        • Mora M.L.
        Central venous catheter-related infection in a prospective and observational study of 2595 catheters.
        Crit Care. 2005; 9: R631-R635
        • Oda T.
        • Hamasaki J.
        • Kanda N.
        • Mikami K.
        Anaphylactic shock induced by an antiseptic-coated central venous [correction of nervous] catheter.
        Anesthesiology. 1997; 87: 1242-1244
        • Terazawa E.
        • Shimonaka H.
        • Nagase K.
        • Masue T.
        • Dohi S.
        Severe anaphylactic reaction due to a chlorhexidine-impregnated central venous catheter.
        Anesthesiology. 1998; 89: 1296-1298
        • Stephens R.
        • Mythen M.
        • Kallis P.
        • Davies D.W.
        • Egner W.
        • Rickards A.
        Two episodes of life-threatening anaphylaxis in the same patient to a chlorhexidine-sulphadiazine-coated central venous catheter.
        Br J Anaesth. 2001; 87: 306-308
        • Jee R.
        • Nel L.
        • Gnanakumaran G.
        • Williams A.
        • Eren E.
        Four cases of anaphylaxis to chlorhexidine impregnated central venous catheters: a case cluster or the tip of the iceberg?.
        Br J Anaesth. 2009; 103: 614-615
        • Sampath L.A.
        • Tambe S.M.
        • Modak S.M.
        In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: evaluation of the risk of bacterial resistance to the antimicrobials in the catheters.
        Infect Control Hosp Epidemiol. 2001; 22: 640-646
        • Tambe S.M.
        • Sampath L.
        • Modak S.M.
        In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices.
        J Antimicrob Chemother. 2001; 47: 589-598